Its weight-loss drug was found to reduce sleep events, the company announced
(Newser) -
Eli Lilly's Zepbound doesn't just lead to weight loss, per the company. A 52-week study found a reduction in obstructive sleep apnea in adults with obesity, the company said Wednesday. Obstructive sleep apnea is a condition in which an upper airway blockage during sleep restricts airflow. People with...